NAOV NanoVibronix
- 0.7001
- -0.0199-2.76%
NanoVibronix News
NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield
NanoVibronix (NAOV) said Tuesday that it has signed a multiyear agreement with CB Medical to sell and distribute the company's UroShield ultrasound-based product. Financial terms were not disclosed. U
NanoVibronix And VA Supplier CB Medical Announce Distribution Agreement For TheUroShield
NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the UroShield, PainShield and WoundShield Surface Acoustic Wave (SAW) Portable Ultrasonic Th
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersHelius Medical Tech (NASDAQ:HSDT) shares increased by 48.9% to $3.96 during Friday's pre-market session. The company's market cap stands at $3.5 million. Vaxxinity (NASDAQ:VAXX) shares moved up
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected results for its second quarter.The company announced a $11
NanoVibronix Announces PainShield To Be Included In Department Of Veteran Affairs FSS Contract Award Effective May 1, 2024
Distribution Partner, Delta Medical, Awarded a Five-Year Federal Supply Schedule Contract for PainShield by Department of Veterans Affairs
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) shares moved upwards by 69.1% to $0.16 during Wednesday's pre-market session. The company's market cap stands at $1.8 million. NanoVibronix (NASDAQ:NAOV) shares moved upwar
NanoVibronix Inc Highlights 2023 Performance and Updates
NanoVibronix Q4 2023 Revenue ~$1.2M
NanoVibronix Q4 2023 Revenue ~$1.2M
NanoVibronix Issues Letter To Stockholders
We are committed to our strategic vision of developing, improving and commercializing our distinct and effective therapies, which we believe enable healthcare providers to treat patients in need, fill
NanoVibronix Enhances Products With Veranex Partnership
NanoVibronix Signs Agreement For Research And Development Of Next Generation PainShield And UroShield
Efforts Focused on Adding Therapeutic Functionality and Reducing CostsNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield, PainShie
NanoVibronix Shares Resume Trade
NanoVibronix Shares Resume Trade
NanoVibronix Shares Halted On Circuit Breaker To The Upside, Stock Now Up 19.8%
NanoVibronix Shares Halted On Circuit Breaker To The Upside, Stock Now Up 19.8%
NanoVibronix Inks Letter Of Intent With APOGEPHA Arzneimittel GmbH To Explore European Distribution Opportunity
NanoVibronix Inks Letter Of Intent With APOGEPHA Arzneimittel GmbH To Explore European Distribution Opportunity
Seelos Therapeutics, Iterum Therapeutics Among Healthcare Movers
NanoVibronix Announces Agreement For Clinical Study Of UroShield At The University Of Michigan
Gathering Additional Clinical Evidence to Support Application to FDA for Permanent ClearanceNanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield, PainShield and Wound
NanoVibronix Regains Nasdaq Compliance
NanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on November 20, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the minimum stockholders' equity requirement of $2.5 million. Accordingly, the previously disclosed listing matter has been closed.
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 11.5% to $0.7 during Monday's after-market session. This security traded at a volume of 109.4K shares come close, making up 23.4% of i
IOVA, YPF and SMR Are Among Pre Market Gainers
NanoVibronix Nov. 13 Reported Q3 2023 EPS $(0.42) Up From $(0.68) YoY, Revenue $458K Up From $97K YoY
NanoVibronix Nov. 13 Reported Q3 2023 EPS $(0.42) Up From $(0.68) YoY, Revenue $458K Up From $97K YoY
Analysis
Price Target
No Data
